Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Telesta Therapeutics Inc. T.BNC

Sector: Healthcare | Sub-Sector: Biotechnology
Primary Symbol: T.TST
Alternate Symbol(s):  BNHLF

Telesta Therapeutics Inc is a human therapeutics company. The Company is engaged in the manufacturing, marketing and licensing/acquisition of proprietary therapies for the global human health market.
Price: $0.365 Volume: 199,732
Change: +$0.01 % Change: +2.82%
Day High/Low: 0.375/0.34 52 Week High/Low: 0.435/0.14
Last Traded: March 27, 2015 11:59 Transaction Volume: 7500
Open: 0.34 Previous Close: 0.355
Bid: 0.365 Ask: 0.37
Bid Size: 40500 Ask Size: 32000
Market Cap: 61.5m Shares Out: 168.6m
PE Ratio: 1.5 Dividend Yield: N/A

Opinion

Physical gold demand soared as price tumbled in 2013

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   January 3, 2014
0 stars

Time to buy more Bioniche (T.BNC) shares?

Stockhouse Editorial   October 29, 2013
0 stars

Bioniche (T.BNC) settles with dissidents: report

Stockhouse Editorial   September 13, 2013
0 stars

Why Bioniche shareholders are angry

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recogni

Stockhouse Editorial   June 13, 2013
0 stars

Latest Bullboard Posts

  • well fck

    0 stars

    E. coli vaccine not effective in feedlot cattle http://www.albertafarmexpress.ca/2015/03/20/e-coli-vaccine-not-effective-in-feedlot...

    1 star


  • RE:But if we hit .50

    3 stars

    Blartar this woe is me "under the radar" story has the full console of built in excuses of failure for a further dilutive financing. But...

    1.5 stars


  • But if we hit .50

    0 stars

    we have 21,006,812 warrants coming due Sept 23-26/ 2015 worth 7,957,127 cash to the company, if they can get exercised . ( 4 million...

    2 stars


  • RE:NO Institutional support

    0 stars

    Correct TXB, but on the upside Pharma are paying incredible premiums for late stage pipeline products. Every week there is a new...

    1.5 stars


  • If it hits 40.

    0 stars

    I'll be content to wait for for awhile longer.

    1 star